Renalytix repays $1.06M of convertible bond via 2.5M shares and $600k cash; remaining principal $13.78M

Renalytix plc

Repayment of $1.06M principal and interest due Jan 7, 2024 using 2.5M ordinary shares and $600k cash.
After settlement, remaining convertible bond principal reduced to $13.78M from $14.84M.
2.5M new ordinary shares admitted to AIM on December 21, 2023; total voting rights become 99,930,156.
Shares issued under Section 3(a)(9) exemption; no registration required.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.